Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Precision medicine: PI3K targeting in advanced breast cancer.
Rocca A, Melegari E, Palleschi M. Rocca A, et al. Among authors: palleschi m. Breast Cancer Res Treat. 2019 Nov;178(2):479. doi: 10.1007/s10549-019-05409-3. Epub 2019 Aug 19. Breast Cancer Res Treat. 2019. PMID: 31428907 Free article. No abstract available.
Ribociclib and Endocrine Therapy in Breast Cancer.
Rocca A, Melegari E, Palleschi M. Rocca A, et al. Among authors: palleschi m. N Engl J Med. 2019 Oct 17;381(16):1592. doi: 10.1056/NEJMc1911188. N Engl J Med. 2019. PMID: 31618549 Free article. No abstract available.
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter.
Bravaccini S, Ravaioli S, Tumedei MM, Rocca A, Palleschi M, Puccetti M, Parrella P, Altini M, Maltoni R. Bravaccini S, et al. Among authors: palleschi m. Clin Cancer Res. 2020 Jul 15;26(14):3892-3893. doi: 10.1158/1078-0432.CCR-20-0668. Clin Cancer Res. 2020. PMID: 32669274 Free article. No abstract available.
Are we ready to use TMB in breast cancer clinical practice?
Ravaioli S, Limarzi F, Tumedei MM, Palleschi M, Maltoni R, Bravaccini S. Ravaioli S, et al. Among authors: palleschi m. Cancer Immunol Immunother. 2020 Oct;69(10):1943-1945. doi: 10.1007/s00262-020-02682-w. Epub 2020 Jul 28. Cancer Immunol Immunother. 2020. PMID: 32725361 Free PMC article.
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.
Palleschi M, Maltoni R, Ravaioli S, Vagheggini A, Mannozzi F, Fanini F, Pirini F, Tumedei MM, Barzotti E, Cecconetto L, Sarti S, Manunta S, Possanzini P, Fedeli A, Curcio A, Altini M, De Giorgi U, Rocca A, Bravaccini S. Palleschi M, et al. Diagnostics (Basel). 2020 Aug 8;10(8):573. doi: 10.3390/diagnostics10080573. Diagnostics (Basel). 2020. PMID: 32784518 Free PMC article.
77 results